Autologous platelet rich plasma (PRP) intraovarian infusion may improve ovarian response to controlled ovarian stimulation as well as the hormonal profile of poor ovarian response infertile women subjected to intracytoplasmic sperm injection (ICSI) treatment.
Age ≥ 40 years
AMH < 1.1 ng/ml OR AFC < 7
≤ 3 oocytes with a conventional stimulation protocol
Discontinuation of any complementary/adjuvant treatment including hormone replacement and acupuncture, for at least three months prior to recruitment.
Any pathological disorder related to reproductive system anatomy
Cycle irregularities
Amenorrhea
Endometriosis
Genesis Athens Clinic
Lead sponsor
National and Kapodistrian University of Athens
Collaborator